Complications of IVF treatment (ovarian hyperstimulation syndrome and/or ovarian bleeding) were reported in two (out of 40) women with NF1 (5.0%) and in four (out of 27) women (14.8%) where the male was affected with NF1 (p = 0.21). This evidence concerns the gene NF1 and neurofibromatosis type 1.